CSL (ASX:CSL) has reported net profit after tax of $1.729 billion for the twelve months ended 30 June 2018, an increase of 29 percent on the previous year, a result "slightly ahead" of the most recent guidance. …
Latest Video
New Stories
-
James McDonnell: Industry 'on the cusp of something quite extraordinary'
September 20, 2019 - - Latest News -
iNova looking for local innovators
September 20, 2019 - - Latest News -
Not a great combination for the sector
September 20, 2019 - - Latest News -
Novartis provides updated data on gene therapy
September 20, 2019 - - Latest News -
Pharmaceutical spend down slightly on Budget forecast
September 19, 2019 - - Latest News -
New study finds link between gene mutation and disease
September 19, 2019 - - Latest News -
New deal for Australian cell therapy company
September 19, 2019 - - Latest News